Company: BNRG
Filing Date: 2025-04-28
Form Type: F-1
Source: 0001213900-25-035754
Chunk: 25

Company: Brenmiller Energy Ltd.
Filing Date: 2025-04-28
Form: F-1
Chunk 25
---
.

<div align='center'>11</div>

The Warrants may not have any value.

Each Warrant has an exercise
price per share equal to $1.332. The Series B Warrants will expire five years from the Initial Exercise Date and the Series C warrants
will expire 12 months from the Initial Exercise Date. In the event the market price per Ordinary Share does not exceed the exercise
price of the Warrants during the period when the Warrants are exercisable, the Warrants may not have any value.

Provisions of the Pre-Funded Warrants and Warrants offered by this prospectus could discourage an acquisition of us by a third party.

Certain provisions of the
Pre-Funded Warrants and Warrants offered by this prospectus could make it more difficult or expensive for a third party to acquire us.
The Warrants and Pre-Funded Warrants prohibit us from engaging in certain transactions constituting “fundamental transactions”
unless, among other things, the surviving entity assumes our obligations under the Warrants and Pre-Funded Warrants. Further, the Warrants
and Pre-Funded Warrants provide that, in the event of certain transactions constituting “fundamental transactions,” with some
exceptions, holders of such warrants will have the right, at their option, to require us to repurchase such Warrants and Pre-Funded Warrants
at a price described in such warrants. These and other provisions of the Pre-Funded Warrants offered by this prospectus could prevent
or deter a third party from acquiring us even where the acquisition could be beneficial to you.

The exercise price of the Pre-Funded Warrants and Warrants offered by this prospectus will not be adjusted for certain dilutive events.

The exercise price of the
Pre-Funded Warrants and Warrants offered by this prospectus is subject to adjustment for certain events, including, but not limited to,
certain issuances of share capital, options, convertible securities and other securities. However, the exercise prices will not be adjusted
for dilutive issuances of securities considered “excluded securities” and there may be transactions or occurrences that may
adversely affect the market price of our Ordinary Shares or the market value of such Pre-Funded Warrants and Warrants without resulting
in an adjustment of the exercise prices of such Pre-Funded Warrants and Warrants

The best efforts structure of this offering may have an adverse effect on our business plan.

The placement agent is offering
the Ordinary Shares, Warrants and Pre-Funded W